Posts for Ticker ‘MHS’

Top 10 Analyst Upgrades, Downgrades, Initiations (ABC, ASML, CAH, CVS, ESRX, INTC, MRVL, MHS, SOLF, TXN)

These are this Thursday’s top ten analyst upgrades, downgrades, and initiations seen in Wall Street research calls:

AmerisourceBergen (NYSE: ABC) Started as Buy at UBS.
ASML (NASDAQ: ASML) Cut to Neutral at B of A Merrill Lynch.
Cardinal Health (NYSE: CAH) Started as Buy at UBS.
CVS Caremark (NYSE: CVS) Started as Buy at UBS.
Express Scripts (NASDAQ: ESRX) Started as Buy at UBS.
Intel Corp. (NASDAQ: INTC) Cut to Neutral at B of A Merrill Lynch.
Marvell Technology Group (NASDAQ: MRVL) Cut to Neutral at B of A Merrill Lynch.
MedcoHealth Solutions Inc. (NYSE: MHS) Started as Buy at UBS.
Solarfun (NASDAQ: SOLF) Raised to Outperform at Oppenheimer.
Texas Instruments Inc. (NYSE: TXN) Cut to Neutral at B of A Merrill Lynch.

You can join our open email distribution list to hear more news on key analyst calls, top day trader alerts, mergers and acquisitions, Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Top Analyst Downgrades (ABB, MT, BDK, BWA, GR, KR, MHS, SNDA)

These are this Thursday morning’s top pre-market analyst downgrades and cautious research calls from Wall Street firms:

ABB (ABB) Cut to Hold at Deutsche Bank.
ArcelorMittal (MT) Cut to Hold at Societe Generale,
Black & Decker (BDK) Cut to Neutral at UBS.
Borg Warner (BWA) Cut to Neutral at KeyBanc.
Goodrich (GR) Cut to Buy from Conviction Buy List at Goldman Sachs.
Kroger (KR) Cut to Equal Weight at Morgan Stanley.
Medco Health (MHS) Cut to Neutral at Goldman Sachs.
Shanda (SNDA) Cut to Sell at Deutsche Bank.

JON C. OGG

Top 10 Pre-Market Analyst Calls (AIG, BARE, CWST, DNA, GILD, MHS, SLAB, TKLC, UBS, WCA)

These are ten of the analyst calls we are seeing early this Thursday morning in early bird pre-market trading hours:

  • American International Group (NYSE: AIG) raised to Buy at Citigroup.
  • Bare Escentuals (NASDAQ: BARE) Raised to Buy from Hold at Citigroup.
  • Casella Waste (NASDAQ: CWST) raised to Overweight at JPMorgan.
  • Genentech (NYSE: DNA) Started as Buy at Deutsche Bank.
  • Gilead (NASDAQ: GILD) Started as Buy at Deutsche Bank.
  • Medco Health Solutions (NYSE: MHS) Cut to Neutral from Buy at UBS.
  • Silicon Laboratories (NASDAQ: SLAB) Raised to Outperform from Market Perform at FBR.
  • Tekelec (NASDAQ: TKLC) Cut to Equal-weight from Overweight at Lehman Brothers.
  • UBS AG (NYSE: UBS) cut to Neutral at Credit Suisse.
  • WCA Waste (NYSE: WCA) Cut To Underweight From Neutral By JP Morgan.

Jon C. Ogg
June 19, 2008

Pharmacy Benefit Managers Dominate Medical Earnings Tuesday (MHS, ESRX)

Pharmacy benefits managers Express Scripts Inc. (NASDAQ: ESRX) and MedcoHealth Solutions Inc. (NASDAQ: MHS) are both set to report earnings on Tuesday.

We’ll get to see earnings out of MedcoHealth Solutions Inc. (NASDAQ: MHS) early Tuesday morning.  The estimates for the pharmacy benefit manager from First Call are $0.53 EPS on $12.25 billion in revenues.  Next quarter estimates are $0.56 EPS on $12.24 billion in revenues. Estimates for fiscal Dec-2008 are $2.30 EPS on $49.40 billion in revenues.  Options traders appear to be braced for a move of $1.40 to $1.70 in either direction.  Analysts have an average price target north of $59.00, and MedCo’s 52-week trading range is $35.12 to $54.63. This closed at $51.31 Monday, so shares are still holding rather well as this is a defensive stock.

Tuesday after the close we’ll get to see earnings out of Express Scripts Inc. (NASDAQ: ESRX), although its management conference call appears to be scheduled for the following morning. The estimates for the pharmacy benefit manager from First Call are $0.67 EPS on $4.78 billion in revenues.  Next quarter estimates are $0.72 EPS on $4.85 billion in revenues. Estimates for fiscal Dec-2008 are $2.98 EPS on $19.44 billion in revenues.  Options traders appear to be braced for a move of close to $3.00 in either direction.  Analysts have an average price target north of $78.00, and Express Scripts’ 52-week trading range is $46.17 to $79.10.  This closed at $73.56 Monday, so shares are still holding rather well as this is also a defensive stock.

Both pharmacy benefit managers took a hit after the first part of the 2008, but shares have recovered and are both within striking distance of their 52-week highs.  As far as defensive stocks for defensive investors, these are supposed to do well regardless of who is in charge of Congress and regardless of who is President.

Jon C. Ogg
April 28, 2008

Top 10 Pre-Market Analyst Calls (BVF, CERN, GIGM, IRBT, MHS, MDP, SII, STLD, STI, TRI)

These are not all of the analyst calls, but these are ten of the calls affecting shares this Wednesday morning:

  • Biovail (NYSE: BVF) cut to Sector Perform at CIBC.
  • Cerner (NASDAQ: CERN) raised to Buy at Jefferies.
  • GigaMedia (NASDAQ: GIGM) started as Nuy at Brean Murray.
  • iRobot (NASDAQ: IRBT) raised to Buy at Kaufman.
  • Medco Health (NYSE: MHS) raised to Outperform at Oppenheimer.
  • Meredith (NYSE: MDP) cut to Hold at Citigroup.
  • Smith International (NYSE: SII) raised to Overweight at JPMorgan; also cut to Perform at Oppenheimer.
  • Steel Dynamics (NASDAQ: STLD) cut to Hold at Citigroup.
  • SunTrust Banks (NYSE: STI) raised to Market Perform at KBW.
  • Triad Hospitals (NYSE: TRI) started as Overweight at JPMorgan.

Jon C. Ogg
April 23, 2008

Top 10 Pre-Market Analyst Calls (ADS, GRMN, HST, JEF, MHS, NCC, RHT, CRM, BRLC, VLTR)

These are some of the top analyst calls that we are focusing on this Tuesday morning in pre-market trading hours:

  • Alliance Data (NYSE: ADS) raised to Overweight at JPMorgan.
  • Garmin Ltd. (NASDAQ: GRMN) started as Neutral at JPMorgan.
  • Host Hotels & Resorts (NYSE: HST) Cut To Hold From Buy By Deutsche Bank.
  • Jefferies Group (NYSE: JEF) Cut to Neutral at Banc of America.
  • Medco Health Solutions (NYSE: MHS) raised to Buy at Jefferies.
  • National City (NYSE: NCC) raised to Buy at Deutsche Bank; Downgraded to Underperform at Bear Stearns.
  • Red Hat (NYSE: RHT) started as Buy at Piper Jaffray.
  • Salesforce.com (NYSE: CRM) started as Buy at Piper Jaffray.
  • Syntax-Brillian (NASDAQ: BRLC) raised to Outperform at Robert W. Baird.
  • Volterra Semi (NASDAQ: VLTR) raised to Buy at Piper Jaffray.

Jon C. Ogg
April 22, 2008

Jon Ogg is a producer of and editor for both the Special Situations newsletter and the "10 Stocks Under $10" weekly newsletter for 247WallSt.com; he can be reached at jonogg@247wallst.com and he does not own securities in the companies he covers.

Medco Health Solutions Files Shelf Registration (MHS)

Medco Health Solutions, Inc. (NYSE: MHS) has just made an SEC Filing that will allow the company to raise capital in the near future if it chooses.  While this could be a large offering, there is actually not an "up to" amount noted, so this is an open filing that will be on the shelf if it chooses.  No underwriters for such offering(s) were designated either.

It lists that it will be able to sell Debt, Preferred shares, common stock, warrants, purchase contracts, and units as the securities that can be sold.  These are actually quite common, although shelf registrations frequently are more specific.

The use of proceeds is also a cookie cutter statement as they are for general corporate purposes, which could include working capital, capital expenditures, acquisitions, refinancing other debt or other capital transactions. This was listed as one of Jim Cramer’s "picks for 5-years out" in previous coverage.

Jon C. Ogg
March 12, 2008

Top 10 Pre-Market Analyst Calls (ARO, ABH, FAST, JCP, JWN, KERX, MHS, AMTR, SHOR, SPLS, VE)

These are some of the analyst calls that 247WallSt.com is focusing on in early pre-market trading this Monday morning:

  • Aeropostale (NYSE: ARO) Cut To Sell From Hold at Citigroup.
  • AbitibiBowater (NYSE: ABH) Raised to Market Perform at Raymond James.
  • Fastenal (NASDAQ: FAST) Started as Equalweight at Morgan Stanley.
  • JC Penney (NYSE: JCP) & Nordstom (NYSE: JWN) Raised to Buy at Goldman Sachs.
  • Keryx Biopharmaceuticals (NASDAQ: KERX) Cut to Neutral at JP Morgan.
  • Medco Health Solutions (NYSE: MHS) Raised to Buy at Goldman Sachs.
  • Omniture (NASDAQ: AMTR) Raised To Outperform at FBR.
  • ShoreTel (NASDAQ: SHOR) Cut to Neutral at Piper Jaffray.
  • Staples (NASDAQ: SPLS) cut to Neutral at Goldman Sachs.
  • Veolia Environnement (NYSE: VE) Raised to Buy at Citigroup.

Jon C. Ogg
March 10, 2008

Top 10 Pre-Market Analyst Calls (AFL, AXP, ABX, CATM, KSS, LOW, LULU, MDAS, MET, MHS, TNK)

It is going to be hard to get traders to care about mere upgrades and downgrades on a day when the Federal Reserve did an inter-meeting emergency rate cut to stave off a 500+ point drop in the DJIA.  But here are some of the calls from analysts today:

  • AFLAC inc. (AFL) raised to Buy from Neutral at Goldman Sachs.
  • American Express (AXP) downgraded to Hold at Citigroup.
  • Barrick Gold (ABX) upgraded to Outperform at Credit Suisse.
  • Cardtronics (CATM) started as Buy at Banc of America; started as Buy at Deutsche Bank; started as Buy at Piper Jaffray.
  • Kohl’s (KSS) & Lowe’s (LOW) raised to Outperform at Bernstein.
  • lululemon althletica (LULU) downgraded to Underperform at BMO Capital.
  • MedAssets (MDAS) started as Buy at Deutsche Bank; started as Neutral at Piper Jaffray; started as Market Perform at Wachovia.
  • MetLife (MET) downgraded to Neutral from Buy at Goldman Sachs.
  • Medco Health Solutions (MHS) cut to Neutral at UBS.
  • Teekay Tankers (TNK) started as Overweight at JPMorgan; started as Hold at Citigroup.

Jon C. Ogg
January 22, 2008

Backward & Forward, Cramer In 2007 To 2008

2007 was one volatile year and for now it appears that will be the norm for at least the start of 2008.  Everyone’s favorite market pundit or least liked pundit is obviously Jim Cramer.  If you love Cramer or can’t stand him it really doesn’t matter.  He signed a new multi-year deal with CNBC recently.  Here are some of his major calls this year that will still be referred to in 2008:

Here were Cramer’s TOP 9 STOCKS FOR 2007, with a call broken down for each one.  Borat would say HI FIVE on some and NOT SO NICE on others, as would be expected.  Cramer’s 14,582 year-end DJIA target…..Friday’s close was 13,365.87……although we did hit 14,279.96 on OCT11, 2007.  Cramer also gave a batch of price targets on most of theDJIA components:

Cramer’s Stock Picks FOR 5-YEARS OUT:

SOME LISTS: His list of recession proof stocks compared to ours.  We are updating our
Defensive Stocks For The First Half Of 2008" currently.  Cramer gave a huge list of companies he expects to benefit from the alternative energy traders (SGR, FWLT, BWA, OMG, FSLR, FTEK, WFR, TTEK, ZOLT, BP, SPWR, CY, CPST, ITRI)… Jim Cramer pondered which US companies China would want to acquire, about 3 months before sovereign funds started buying into US companies.  Cramer’s mortgage winners and losers…… Here were his MAJOR BULL MARKET STOCK PICKS(MHS, CVS, AGN, CELG, GENZ, CEPH, RIG, HAL, EMR, CAT, CMI, UTX, KO,PEP, CL, GS, SKS, VFC, UNP, CSX, BA), some of which are DJIAcomponents.  Cramer produced a "MUST OWN" list of stocks, many of whichare up significantly and some are down (WHR, BDK, ATI, BGC, HON, ASD, JCI, MDR, FWLT, CAT, TEX, DE, QCOM)

Cramer spent lots of time on International stocks that most US investors might not cover on their own.  He made a big call on Mercadolibre (MELI) (also BIDU, GOOG) with some emphasis on buying immediately, right before it made a huge run up.  Cramer’s Hidden Video Game Investment Perfect World (PWRD, ATVI, ERTS, VIA) was one he said could run more than 50% for 2008.  Cramer made 5 TOP CHINESE PICKS (CEO, CHL, SSW, FMCN, BIDU, GMR).  We’ll see in 2008 if any of his Canadian OIL TRUSTS get acquired in 2008 (BTE, CNE, PGH, PVX, PWE, AAV, GDI).  Cramer also went over his top picks from Europe for American investors (TOT, SI, ABB, PHG, BF)

ON TECHNOLOGY:  Cramer’s NEW HORSEMEN OF TECH…. will the list change in 2008???  Did Cramer Say $1,000.00 on Google, Or Is It $600.00? That was in May 2007.  Cramer Gave Monster Price targets to Baidu.com (BIDU, GOOG).. will these targets change in 2008? Cramer was very positive on all the GPS stocks,although we’d expect that Cramer will change his tune in 2008 now thatthe holiday madness is behind us (GRMN, UA, CROX, NVT, TRMB, SIRF).

Would it be fair not to include the Barron’s attack on Cramer from summer for those of you that criticize his every word?

ON WARREN BUFFETT…. Cramer noted that BROOKFIELD ASSET MANAGEMENT in Canada may be the next Berkshire Hathaway (NYSE:BRK/A) NYSE: BAM). Cramer reviewed 10 Warren Buffett stocks for analysis and then reviewed 10 More Warren Buffett stocks:

Will his buyout of ALCOA (AA) prediction come true in 2008??? Cramer gave a list of stocks that had bought back so much stock that they might be taking themselves private.

Join our free email distribution list for other Cramer calls or for updates we send out regarding IPO’s, spin-offs, restructuring, reorganization, activist investors and more.

Happy New Years from the 247WallSt.com team!

Jon C. Ogg
December 31, 2007

Pre-Market Stock News (December 18, 2007)

Below is the top news that 247WallSt.com is focusing on that is impacting stocks in pre-market trading activity:

  • Adobe Systems (ADBE) traded down 2% after beating earnings and slightly raised guidance.
  • ATS Medical (ATSI) received FDA approval for AP360 mechanical heart valve.
  • Best Buy (BBY) $0.53 EPS vs $0.41 est. and $9.92 Billion revenues vs. $9.45 Billion est.; shares traded up 4%.
  • Borg Warner (BWA) trades ex-split to reflect a 2 for 1 stock split today.
  • Cherokee (CHKE) retained Goldman, Sachs & Co. to explore strategic alternatives including possible sale of the company.
  • Dollar Financial (DLLR) raised fiscal 2008 guidance after formally closing its previously announced acquisition of 82 Florida financial-services stores.
  • Eli Lilly (LLY) announced that CEO Sidney Taurel will retire in March 2008.
  • First Solar (FSLR) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.
  • Forest Labs (FRX) won FDA approval for its new high blood pressure beta blocker along with Maylan Labs.
  • Goldman Sachs (GS) set to report earnings with $6.61 EPS estimate (whisper of $7.00 and higher).
  • Natus Medical (BABY) put Q1 guidance $0.09-0.10 vs $0.12 estimate; sees 2008 EPS $0.68 to $0.70 vs. $0.63 estimate.
  • MedcoHealth Solutions (MHS) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.
  • Mylan Labs (MYL) won FDA approval for its new high blood pressure beta blocker along with Forest Labs.
  • Range Resources (RRC) to replace Tribune in S&P 500 Index on Thursday after close.
  • Salix Pharmaceuticals (SLXP) will replace Coherent Inc. (COHR) in the S&P SmallCap 600 after the close TODAY.
  • Synovus (SNV) lowered its guidance.
  • Thornburg (TMO) reinstated dividend with $0.25 payment, says mortgage uncertainties continue.
  • Transocean (RIG) noted as a stock pick with 5-years earnings visibility by Cramer on MAD MONEY.

Jon C. Ogg
December 18, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.

Cramer’s Second Pick For Five Years Out: MedcoHealth (MHS)

On tonight’s MAD MONEY on CNBC, Jim Cramer said he wanted to review some picks that you might want to own with a 5-year time horizon for the future.  He wants to look beyond the current markets and the volatility, so he wants to look at earnings visibility for a multi-year period.  So that way he can look past a major market swing or against an analyst panicking over a stock drop.  He has three picks that have 5-years worth of visibility and his SECOND PICK is as follows:

  • Cramer’s second pick for 5-years out tonight was MedcoHealth Solutions, Inc. (NYSE:MHS).  Cramer loves the visibility on, and the drops recently allow you to get it cheaper.  The pharmacy benefit manager is one of the healthcare cost containment companies and that sector has huge visibility.  They even make more when big brand drugs lose their patents, and $77 Billion worth of blockbuster drugs are coming off patent in the coming years.  This allows MedcoHealth to pit the drug sellers against each other and it gets to make more off customers than you’d expect.  The growth is visible and he thinks there is a $6 Billion gain coming in profits.  Cramer also loves its higher margin tailored drug program and its mail order business, but he really loves the visibility to 2012.

His first pick was First Solar and you can see that here.

Here are some other Cramer highlights:

Here is our own open email distribution list where we highlight some other Cramer picks, buyouts, break-ups, spin-offs, value stocks, merger-arb, and more.

Jon C. Ogg
December 17, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.

Additional Pre-Market Stock News (November 29, 2007) (ENB, EEP, FRED, HNZ, LULU, MHS, MW, VSE, USBE, ULBI, VIP, SIGM)

Below is some of the other top summaries of news we haven’t covered this morning:

Enbridge Inc. (ENB) and Enbridge Energy Partners, L.P. (EEP) had a pipeline blow late yesterday that has oil up as much as $4 today; two workers were killed; the explosion and fire on an Enbridge Energy Partners’ crude oil pipeline approximately three miles southeast of Enbridge’s Clearbrook, Minnesota terminal is apparently one of the Canadian pipelines that comes down to the U.S. and it is a supply risk.
Fred’s (FRED) $0.12 EPS after $0.02 "timing event" versus $0.14 estimate; hired Merrill Lynch to help it review strategic alternatives after receiving interest from multiple parties.
HJHeinz (HNZ) $0.71 EPS vs $0.69 est.; put guidance at higher end of range for next quarter.
Lululemon (LULU) trading up 10% after beating earnings and raising guidance.
Medco Health (MHS) announced a 2 for 1 stock split.
Men’s Wearhouse (MW) trading down 12% after disappointing earnings.
Sigma Designs (SIGM) traded up 14% after posting $0.79 EPS vs $0.54 estimates.
Ultralife Batteries (ULBI) receive a $2.6 million order from the U.S. Defense Department.
VeraSun Energy (VSE) and US BioEnergy (USBE) are going to merge operations into a single company; USBE shares up 8%.
Vimpel-Comm (VIP) trading up 5% after beating earnings expectations.
WellCare Health Plans, Inc. (WCG) traded up 10% after-hours after announcing that on November 21, it received an executed Contract between the Centers for Medicare & Medicaid Services. This one had been battered after that FBI raid killed the stock in recent weeks.

Jon C. Ogg
November 29, 2007

Cramer’s Recession Draft Picks (PEP, MHS, MO, NOC, MCD, PG)

On tonight’s MAD MONEY, Jim Cramer said he was equating a stock picking portfolio like a fantasy football draft.  He has been discussing rising unemployment, houses being lost, and a recession coming for months.  As far as the FED cutting rates, he thinks the FED will only cut rates by 0.25% this month instead of the 0.50% rate cut that is needed.  The Fed governor speeches today noted that the ‘weak jobs numbers’ are a trend rather than a one-instance. Cramer said that he is creating a draft list of stock picks like a fantasy football team that he thinks can make money regardless of the Fed being late on policy.  On Friday, I gave a huge list of 17 defensive stocks that we edited from prior defensive stock lists.  Here are some of Cramer’s picks:

A defensive lineman draft is Pepsico (NYSE:PEP), and another is Medco Health (NYSE:MHS) for cost controls in medical and drugs.  Altria (NYSE:MO) is also on there with a 4.4% yield. Northrup Grumman (NYSE:NOC) is also on his list and the business has no dependence on the Fed.  McDonald’s (NYSE:MCD) is on his list, and Proctor & Gamble (NYSE:PG) made his list tonight.  Four of Cramer’s Six Picks were on my list from Friday morning.

Jon C. Ogg
September 10, 2007

Pre-Market Analyst Calls (June 7, 2007)

ASML raised to Outperform at Bernstein.
CENT cut to Neutral at B of A.
COBZ raised to Outperform at KBW.
DCP raised to Outperform at CIBC.
DGX raised to Buy at UBS.
ECL raised to Buy at Jefferies.
FNM raised to Outperform at FBR.
GD raised to Overweight at Lehman.
HC raised to Overweight at JPMorgan.
IFX raised to Mkt Perform at Bernstein.
IO started as Buy at Jefferies.
KBR started as Outperform at Credit Suisse.
MHS raised to Buy at UBS.
MKC raised to Outperform at Bear Stearns.
OPTM started as Sector Perform at CIBC.
OREX started as Overweight at JPMorgan.
PDLI cut to Mkt Perform at Wachovia.
PG cut to Equal Weight at Lehman.
RDWR raised to Outperform at CIBC.
VOLV cut to Underweight at JPMorgan.
VRUS started as Outperform at JMP Securities.

Jon C. Ogg
June 7, 2007

Cramer’s 21 Major Bull Market Stock Picks (2)

Stock Tickers: MHS, CVS, AGN, CELG, GENZ, CEPH, RIG, HAL, EMR, CAT, CMI, UTX, KO, PEP, CL, GS, SKS, VFC, UNP, CSX, BA

On Thursday evening, Jim Cramer came out very bullish again on CNBC’s MAD MONEY.  Cramer said you better know what is working and what isn’t.Cramer said the analysts were giving out estimates like they were allgoing to be horrible and full of gloom and doom.  Even companies thathave been inconsistent are becoming consistent and estimates are beingretooled and companies are being revalued. Cramer again said the DJIAis heading straight to 14,000, but some sectors have peaked.  Here is the full summary:

Read More »

Cramer’s 21 Major Bull Market Stock Picks

Stock Tickers: MHS, CVS, AGN, CELG, GENZ, CEPH, RIG, HAL, EMR, CAT, CMI, UTX, KO, PEP, CL, GS, SKS, VFC, UNP, CSX, BA

Jim Cramer came out very bullish again (you get the trend here) as much as he could on tonight’s MAD MONEY on CNBC.  He’s still maintaining that yesterday was only the beginning and this is the start of a major rally, and you better know what is working and what isn’t.  Cramer said the analysts were giving out estimates like they were all going to be horrible and full of gloom and doom.  Even companies that have been inconsistent are becoming consistent and estimates are being retooled and companies are being revalued. Cramer again said the DJIA is heading straight to 14,000, but some sectors have peaked.

Healthcare: Medco (MHS-NYSE), CVS (CVS-NYSE) and Allergan (AGN-NYSE)

Celgene (CELG-NASDAQ), Genzyme (GENZ-NASDAQ), and Cephalon (CEPH-NASDAQ)

Oil Drillers: Transocean (RIG-NYSE), Halliburton (HAL-NYSE)

Capital Goods: Emerson (EMR-NYSE), Caterpillar (CAT-NYSE), Cummins (CMI-NYSE), United Technologies (UTX-NYSE)

Household Coca-Cola (KO-NYSE), Pepsi (PEP-NYSE), and Colgate Polmolive (CL-NYSE)

Brokers: Goldman Sachs (GS-NYSE)

Retail: Saks (SKS-NYSE), VF Corp (VFC-NYSE)

Rails: Union Pacific (UNP-NYSE) and CSX (CSX)

Planes/Aerospace:  Boeing (BA-NYSE)

He also noted that companies in Materials, Agriculture, Brokers, & Telecom but he gave no picks there.  These may be able to pick apart and many may slam Cramer, but he’s been right on the directions so far this time around.

Jon C. Ogg
April 26, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.